Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2007 1
2008 1
2009 1
2010 2
2019 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Primary colorectal lymphoma.
Musallam KM, Hatoum HA, Barada K, Taher AT, Salem ME, Malek EM, Shamseddine AI. Musallam KM, et al. Med Oncol. 2010 Jun;27(2):249-54. doi: 10.1007/s12032-009-9200-5. Epub 2009 Mar 20. Med Oncol. 2010. PMID: 19301158
This study aimed at investigating the incidence, presentation, patient and tumor characteristics, treatment, and outcome of primary colorectal lymphomas (PCL) at a tertiary care center in Lebanon over a 25-year period. ...The medical records were reviewed for demogr …
This study aimed at investigating the incidence, presentation, patient and tumor characteristics, treatment, and outcome of primary color …
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
Zhang H, Qureshi MA, Wahid M, Charifa A, Ehsan A, Ip A, De Dios I, Ma W, Sharma I, McCloskey J, Donato M, Siegel D, Gutierrez M, Pecora A, Goy A, Albitar M. Zhang H, et al. Am J Pathol. 2023 Jan;193(1):51-59. doi: 10.1016/j.ajpath.2022.09.006. Epub 2022 Oct 13. Am J Pathol. 2023. PMID: 36243045 Free article.
Geometric mean naive Bayesian algorithm was trained using 3045 samples and tested on 1415 samples, and showed correct first-choice diagnosis in 100%, 88%, 85%, 82%, 88%, 72%, and 72% of acute lymphoblastic leukemia, acute myeloid leukemia, diffuse large B-cell lymphoma, …
Geometric mean naive Bayesian algorithm was trained using 3045 samples and tested on 1415 samples, and showed correct first-choice diagnosis …
Primary colorectal diffuse large B-cell lymphoma: A report of eighteen cases in a tertiary care center.
Vasconcelos FDC, Araujo ROC, Bernardo PS, Hancio T, de Moraes GN, Bigni RS, Valadão M, Pinto LW, Maia RC. Vasconcelos FDC, et al. Cancer Treat Res Commun. 2023;36:100722. doi: 10.1016/j.ctarc.2023.100722. Epub 2023 May 24. Cancer Treat Res Commun. 2023. PMID: 37331034 Free article.
Primary colorectal diffuse large B-cell lymphoma (DLBCL) is very rare colon malignancy. ...Our results are consistent with previous publications and address the importance of correct colorectal DLBCL diagnosis and treatment....
Primary colorectal diffuse large B-cell lymphoma (DLBCL) is very rare colon malignancy. ...Our results are consistent with pre …
Primary Colorectal Lymphoma: Institutional Experience and Review of a National Database.
Hangge PT, Calderon E, Habermann EB, Glasgow AE, Mishra N. Hangge PT, et al. Dis Colon Rectum. 2019 Oct;62(10):1167-1176. doi: 10.1097/DCR.0000000000001279. Dis Colon Rectum. 2019. PMID: 30489325
BACKGROUND: Primary colorectal lymphoma is rare, representing 0.2% to 0.6% of all colorectal cancers. ...OBJECTIVE: The purpose was to report the experience of primary colorectal lymphoma in an institutional and a national cohort. DESIGN: This w …
BACKGROUND: Primary colorectal lymphoma is rare, representing 0.2% to 0.6% of all colorectal cancers. ...OBJECTIVE: The …
Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease.
Smith MA, Irving PM, Marinaki AM, Sanderson JD. Smith MA, et al. Aliment Pharmacol Ther. 2010 Jul;32(2):119-30. doi: 10.1111/j.1365-2036.2010.04330.x. Epub 2010 Apr 16. Aliment Pharmacol Ther. 2010. PMID: 20412066 Free article. Review.
METHODS: Search terms included 'malignancy' 'cancer' 'azathioprine' 'mercaptopurine' 'tioguanine (thioguanine)' 'thiopurine' and 'inflammatory bowel disease' 'Crohn's disease' 'ulcerative colitis'. We also searched for specific cancers (lymphoma, colorectal cancer, …
METHODS: Search terms included 'malignancy' 'cancer' 'azathioprine' 'mercaptopurine' 'tioguanine (thioguanine)' 'thiopurine' and 'inflammato …
Influence of social networks on cancer survivors' self-management support: A mixed methods study.
Howard-Jones G, Vassilev I, Fenlon D, Ewings S, Richardson A. Howard-Jones G, et al. Eur J Cancer Care (Engl). 2022 May;31(3):e13578. doi: 10.1111/ecc.13578. Epub 2022 Apr 13. Eur J Cancer Care (Engl). 2022. PMID: 35416341 Free PMC article.
METHODS: The study used a sequential, exploratory mixed methods design. Phase 1 surveyed 349 lymphoma, colorectal, breast and prostate cancer survivors. Phase 2 analysed 20 semi-structured interviews with respondents recruited from Phase 1. ...
METHODS: The study used a sequential, exploratory mixed methods design. Phase 1 surveyed 349 lymphoma, colorectal, breast and …
The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer.
Camidge DR. Camidge DR. Clin Lung Cancer. 2007 Jul;8(7):413-9. doi: 10.3816/CLC.2007.n.024. Clin Lung Cancer. 2007. PMID: 17681093 Review.
These agents appear well tolerated with hints of single-agent activity in lymphoma, colorectal cancer, chondrosarcoma, and non-small-cell lung cancer. ...Provided that a wide therapeutic margin relative to normal cells can be maintained, maximizing apoptotic …
These agents appear well tolerated with hints of single-agent activity in lymphoma, colorectal cancer, chondrosarcoma, and non …
Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients.
Li B, Shi YK, He XH, Zou SM, Zhou SY, Dong M, Yang JL, Liu P, Xue LY. Li B, et al. Int J Hematol. 2008 May;87(4):375-381. doi: 10.1007/s12185-008-0068-5. Int J Hematol. 2008. PMID: 18409078
Ileum was the most commonly involved site (8 of 14 patients, 57.1%), followed by jejunum (2 of 14 patients, 14.3%) and duodenum (1 of 14 patients, 7.1%). Twenty-five patients had primary colorectal lymphoma, with B-cell origin accounting for 92.0% and T-cell origin …
Ileum was the most commonly involved site (8 of 14 patients, 57.1%), followed by jejunum (2 of 14 patients, 14.3%) and duodenum (1 of 14 pat …
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).
Cheung CC, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F, Couture C, Deschenes J, El-Zimaity H, Fischer G, Fiset PO, Garratt J, Geldenhuys L, Gilks CB, Ilie M, Ionescu D, Lim HJ, Manning L, Mansoor A, Riddell R, Ross C, Roy-Chowdhuri S, Spatz A, Swanson PE, Tron VA, Tsao MS, Wang H, Xu Z, Torlakovic EE; Canadian Association of Pathologists-Association Canadienne Des Pathologistes’ National Standards Committee for High Complexity Testing (CAP-ACP NSCHCT). Cheung CC, et al. Appl Immunohistochem Mol Morphol. 2019 Nov/Dec;27(10):699-714. doi: 10.1097/PAI.0000000000000800. Appl Immunohistochem Mol Morphol. 2019. PMID: 31584451 Free PMC article.
Since 2014, programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) checkpoint inhibitors have been approved by various regulatory agencies for the treatment of multiple cancers including melanoma, lung cancer, urothelial carcinoma, renal cell carcinoma, hea …
Since 2014, programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) checkpoint inhibitors have been approved by variou …
The psychosocial needs of cancer patients: findings from an observational study.
McIllmurray MB, Thomas C, Francis B, Morris S, Soothill K, Al-Hamad A. McIllmurray MB, et al. Eur J Cancer Care (Engl). 2001 Dec;10(4):261-9. doi: 10.1046/j.1365-2354.2001.00280.x. Eur J Cancer Care (Engl). 2001. PMID: 11806677
The participants were 1,000 patients from four hospitals in the north west of England with the following characteristics: tumour type (breast, colorectal, lymphoma, lung), being 1 month from a 'critical moment' in the cancer journey (i.e. (i) diagnosis, (ii) end of …
The participants were 1,000 patients from four hospitals in the north west of England with the following characteristics: tumour type (breas …